Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Michel van Gelder*, Dimitris Ziagkos, Liesbeth de Wreede, Anja van Biezen, Peter Dreger, Martin Gramatzki, Matthias Stelljes, Niels Smedegaard Andersen, Nicolaas Schaap, Antonin Vitek, Dietrich Beelen, Vesa Lindstrom, Juergen Finke, Jacob Passweg, Matthias Eder, Maciej Machaczka, Julio Delgado, William Krueger, Ludek Raida, Gerard SociePavel Jindra, Boris Afanasyev, Eva Wagner, Yves Chalandon, Anja Henseler, Stefan Schoenland, Nicolaus Kroeger, Johannes Schetelig, CLL Subcomm Chronic Malignancies W, European Soc Blood Marrow Transpla

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)667-675.e2
Number of pages11
JournalClinical Lymphoma Myeloma & Leukemia
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 2017

Keywords

  • del(17p)
  • HLA-matched donor
  • Kinase- and BCL2 inhibitor refractory
  • Non-relapse mortality
  • Risk factor analysis
  • MATCHED UNRELATED DONOR
  • MARROW TRANSPLANTATION
  • EUROPEAN-SOCIETY
  • FOLLOW-UP
  • RELAPSED CLL
  • IBRUTINIB
  • SURVIVAL
  • BLOOD
  • MULTICENTER
  • THERAPY

Cite this